Ron Bourquin, Cma Mba Email & Phone Number

Activist for Veterans; taking care of our Children - food, housing, education; Political reform; Corporate Governance reform - obscene salaries, bonuses, stock awards and parachutes - including Board of Director reform; Food and Drug administration for "good old boy" companies and their relationships to government officials; support Prevention for Cruelty to Animals; technologist.....

Us

CFO Gratis for seed-stage Company with evolutionary next generation technology for product in large disposable market in the medical device industry. There have been no new products in this market for years. The original product is a brutal, tissue damaging procedure that has no current alternative and requires constant hospital staff attention after implantation to attempt to avoid infection. This product has been designed for reducing infection, better wound care and reduction of hospital costs. (Infections caused by hospital/provider will not be reimbursable, so hospital eats the cost of that part of treatment). I have contributed countless hours to the Business Plan, Financial forecast, Cash Flow forecasting, setting up legal documentation - hiring new outside counsel, setting up website, seeking seed funding, interaction with/contact Angel Investors and certain VC's, with an eye toward raising money.

* Sr. Dir. Finance - medical devices for recently approved product in cardiology space; HR and IT; hired 5 reps and mfg people during medical leave of incumbent; renew corporate insurance; stock option reconciliation; physical inventory reconciliation.* Reviewed S-1 rewrites - International Internet advertising.* Sr. Dir. Finance - Biotech; medical leave; manage staff of 5.* CFO unplanned departure; assumed all duties; expanded to include ERP, forecasts, inventory, search for new facility.* CFO - small medical device company; milestones for additional funding.* CFO - in-revenue medical device company in drug delivery by catheters; strategic initiative to sell company; updated valuation, first outside audit.* CFO - R & D medical device company - pulmonary space.* CFO for small cable tv company w/mid-size regional customers.* CFO - software security company; steep revenue growth; sales & use tax issues; revenue recognition; sales comp plans; advised CEO for Series A ~ $21M; valuations; stock option pricing & entries to P & L; secured $1.5M credit line.* SEC Consultant for large semiconductor co.; restatement of revenue & expenses due to purported option manipulation by CEO & CFO.* CFO/Controller; small, R & D biotech. Manage financials; actual/budget; cash flow.* SEC Consultant; large telecom IPO preparing S-1 initial filing.

Advising CEO/surgeon/developer of evolutionary product with novel changes in design, materials and costs. Mainly project-based to set up financials, forecasts, cash flow, raise seed round, help negotiate contracts with vendors and advise CEO on all business matters. All personal capital to date. Close to OUS approvals and filing for 510(k) by mid-summer. High volumes with relatively fast break-even point; product to be manufactured in U. S. Seeking seasoned seed-stage VC investor to provide financial and other business resources. CEO intends on keeping company virtual to reduce cost and red-tape and we have talked to many vendors doing the same for other companies.

CFO for VC funded start-up medical device company that was supposed to have approval and sales ramp within one year to sell. However, things change; we didn't have a reliable supply chain, causing shortages; also responsible for complex forecast/build plan; assist CEO in proposal to Board to expand manufacturing and become our own second source, responsible for finding new facility; negotiating lease and L/H improvements; found a facility with a previous medical device manufacturer moving out, but using a certified clean room that just needed filters and re-certification; HR, IT, facilities, materials and purchasing. Sub-let old space. Series C raised almost $28M. Purchased IP from competitor who was going bankrupt. First start-up for CEO, so it was a teaching/learning experience; after funding completed, realized sales forecast too aggressive; someone gets thrown under the bus. Guess who? Not the worst thing in the world. One year ended up seven with a couple more financing events. VC's only concern was extended time frame for ramp, multiple additional financing's and getting to substantial revenue number. Eventually sold to Covidien.

Us

CFO; did IPO and multiple private placements. Accounting, finance, HR, IT, investor relations, corporate governance issues - NASDAQ listing issues; raised more than $100M in equity, debt and through IP sales and U.S. distribution agreements. Investor relations, authored press releases; SEC reports; Corporate presentations; Road shows and financial conferences. Company failed to obtain FDA approval for differences in data and trials. Because the CEO had told investors that approval was a slam dunk, when we didn't get it there was a sizable sell-off. I mapped out cuts and restructuring which the CEO wouldn't do, so that was an unfortunate end for all the hard work.

Marlborough, Ma, Us

Controller for EP Technologies, Inc., acquired by BSX in January 1996. Transition team, knowledge transfer, due diligence, liaison with legal, including FTC submission and corporate accounting groups at BSX.

Revise and update cost accounting information under just-installed software package. Staff upgrade for pending IPO and public company status. Prepared and participated in S-1 drafting for IPO and follow-on offering at 50% premium to IPO. Due diligence and Federal Trade Commission testing for merger with Boston Scientific. Sales and use tax issues with several states settled; resolved labor classification claim by Dept. of Labor; Finance leader for transition team to BSX.

Kalamazoo, Mi, Us

Corporate Controller for fastest growing Stryker entity. Grew from approximately $35M to $100M in sales of minimally-invasive surgical products in one year, including instruments, disposables and capital equipment as endoscopic surgery exploded onto market.

Worldwide Finance Director for Medical Group - Revenue to $100M of disposables and capital equipment. Lasers to treat diseases of the eyes, general surgery, aesthetic surgery and orthopedic surgery.

Financial and Budget Analyst for part of company that manufactured clinical accelerators for cancer treatment, ultrasound diagnostic equipment and CT Scanners. All three split out as separate divisions of the Medical Group. Prepared return on investments; reported engineering project financial results to senior management.

Physical inventories of ~ 14 retail and three wholesale growing chain of hardware and lumber stores. Responsible for asset security: petty cash, inventory and capital equipment.

Randolph Afb, Tx, Us

CryptographyCryptologyRadio Intercept Analyst